Literature DB >> 30496853

Characterization of circulating tumor cells as a reflection of the tumor heterogeneity: myth or reality?

Hannah K Brown1, Marta Tellez-Gabriel2, Pierre-François Cartron3, François M Vallette3, Marie-Francoise Heymann3, Dominique Heymann4.   

Abstract

The current main goal of diagnostic medicine is to detect crucial events in 'infinitely' small samples. The key question now is how to determine whether the rare cell events isolated and characterized from these samples reliably reflect the disease and heterogeneity of the tumor. In this review, we provide a short overview of the most recent methods developed for the isolation and characterization of rare cell events in clinical practice, with a specific focus on circulating tumor cells. We discuss the biological value to studying these cells at the single cell level and how these rare cell events can reflect tumor heterogeneity. The potential biomedical applications are also critically discussed in light of precision medicine. Crown
Copyright © 2018. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30496853     DOI: 10.1016/j.drudis.2018.11.017

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  14 in total

Review 1.  Unraveling Cancer Metastatic Cascade Using Microfluidics-based Technologies.

Authors:  Maziar Hakim; Leyla Kermanshah; Hesam Abouali; Hanieh Mohammad Hashemi; Alireza Yari; Farhad Khorasheh; Iran Alemzadeh; Manouchehr Vossoughi
Journal:  Biophys Rev       Date:  2022-04-14

2.  Enumeration And Characterization Of Circulating Tumor Cells And Its Application In Advanced Gastric Cancer.

Authors:  Boran Cheng; Gangling Tong; Xuan Wu; Wenwu Cai; Zhu Li; Zhongyi Tong; Lirui He; Shaokang Yu; Shubin Wang
Journal:  Onco Targets Ther       Date:  2019-09-25       Impact factor: 4.147

3.  Circulating tumor cells in whole process management of gastrointestinal stromal tumor in a real-life setting.

Authors:  Qiang Zhang; Kangjing Xu; Ming Chen; Yongchang Miao; Nuofan Wang; Zekuan Xu; Hao Xu
Journal:  Saudi J Gastroenterol       Date:  2020 May-Jun       Impact factor: 2.485

Review 4.  Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity.

Authors:  Marta Tellez-Gabriel; Marie-Françoise Heymann; Dominique Heymann
Journal:  Theranostics       Date:  2019-06-19       Impact factor: 11.556

Review 5.  Sarcoma treatment in the era of molecular medicine.

Authors:  Thomas Gp Grünewald; Marta Alonso; Sofia Avnet; Ana Banito; Stefan Burdach; Florencia Cidre-Aranaz; Gemma Di Pompo; Martin Distel; Heathcliff Dorado-Garcia; Javier Garcia-Castro; Laura González-González; Agamemnon E Grigoriadis; Merve Kasan; Christian Koelsche; Manuela Krumbholz; Fernando Lecanda; Silvia Lemma; Dario L Longo; Claudia Madrigal-Esquivel; Álvaro Morales-Molina; Julian Musa; Shunya Ohmura; Benjamin Ory; Miguel Pereira-Silva; Francesca Perut; Rene Rodriguez; Carolin Seeling; Nada Al Shaaili; Shabnam Shaabani; Kristina Shiavone; Snehadri Sinha; Eleni M Tomazou; Marcel Trautmann; Maria Vela; Yvonne Mh Versleijen-Jonkers; Julia Visgauss; Marta Zalacain; Sebastian J Schober; Andrej Lissat; William R English; Nicola Baldini; Dominique Heymann
Journal:  EMBO Mol Med       Date:  2020-10-13       Impact factor: 12.137

6.  Extracellular Vesicles Induce an Aggressive Phenotype in Luminal Breast Cancer Cells Via PKM2 Phosphorylation.

Authors:  Seo Young Kang; Eun Ji Lee; Jung Woo Byun; Dohyun Han; Yoori Choi; Do Won Hwang; Dong Soo Lee
Journal:  Front Oncol       Date:  2021-12-13       Impact factor: 6.244

7.  Optimization of the Enrichment of Circulating Tumor Cells for Downstream Phenotypic Analysis in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1 Immunotherapy.

Authors:  Maria A Papadaki; Afroditi I Sotiriou; Christina Vasilopoulou; Maria Filika; Despoina Aggouraki; Panormitis G Tsoulfas; Christina A Apostolopoulou; Konstantinos Rounis; Dimitrios Mavroudis; Sofia Agelaki
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

Review 8.  Emerging Role of Circulating Tumor Cells in Gastric Cancer.

Authors:  Phung Thanh Huong; Sanjeev Gurshaney; Nguyen Thanh Binh; Anh Gia Pham; Huy Hoang Nguyen; Xuan Thanh Nguyen; Hai Pham-The; Phuong-Thao Tran; Khanh Truong Vu; Nhuong Xuan Duong; Claudio Pelucchi; Carlo La Vecchia; Paolo Boffetta; Hung D Nguyen; Hung N Luu
Journal:  Cancers (Basel)       Date:  2020-03-15       Impact factor: 6.639

Review 9.  Tracking cancer progression: from circulating tumor cells to metastasis.

Authors:  Francesc Castro-Giner; Nicola Aceto
Journal:  Genome Med       Date:  2020-03-19       Impact factor: 11.117

10.  Long Noncoding RNA NONHSAT079852.2 Contributes to GBM Recurrence by Functioning as a ceRNA for has-mir-10401-3p to Facilitate HSPA1A Upregulation.

Authors:  Ningning Zhao; Jiajie Zhang; Lili Zhao; Xiaoni Fu; Qian Zhao; Min Chao; Haiyan Cao; Yang Jiao; Yaqin Hu; Chao Chen; Liang Wang; Huijuan Wang
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.